The Road to Commercial-Scale iPSC Cell Therapy

• August 19, 2026

Impact of cognitive impairment on postoperative delirium and discharge disposition following knee arthroplasty: a Japanese nationwide propensity score–matched study

• by Yu Mori, Kunio Tarasawa, Hidetatsu Tanaka, Ryuichi Kanabuchi, Naoko Mori, Kiyohide Fushimi, Toshimi Aizawa, Kenji Fujimori

• August 14, 2026

FDA Clears Exoskeleton for Spinal Cord Injury

Use is limited to level indoor and adjoining outdoor areas and requires supervision by a companion with specialized training.

• by Kathryn Wighton

• August 12, 2026

• 2 min

FDA approves tau PET imaging agent

The F18-labeled agent is indicated for brain PET imaging to identify tau neurofibrillary tangle pathology.

• by Kathryn Wighton

• August 14, 2026

• 2 min